ANANDA PHARMACY

GENERIC NAME : ERYTHROMYCIN "BRANDS ARE JUST A NAME NOT THE QUALITY IN CASE OF MEDICINE " . IF THE DRUG IS PRESCRIBED IN A NEAT MANNER THAT A PHARMACIST CAN EASILY UNDERSTAND AND DELIVER THE DRUG IN APPROPRIATE TO THE PRESCRIPTION  ADVANTAGES OF GENERIC NAME PRESCRIBING: 1. UNETHICAL MARKETING WOULD BE STOPPED. 2. CORRECT DOSE TO THE PATIENT WOULD BE GIVEN . 3. EXPIRY OF DRUGS WILL BE LESS AND WASTAGE OF DRUGS WILL BE LESS. 4. COST EFFECTIVE. 5. CORRECT TREATMENT WOULD BE PROVIDED RATHER THE UNETHICAL OFFERINGS PRESCRIPTION WRITTEN BY THE CORPORATE SOCIETY. 6.LESS CONFUSION. 7. STRONG RELATIONSHIP BETWEEN DOCTORS-PATIENT-PHARMACIST. 8. GETTING FREE TIME TO GAIN KNOWLEDGE FROM A JOURNAL WITHOUT SPENDING TIME WITH REPRESENTATIVES HEARING THE SAME LOOP EVERY WEAK OR EVERY DAY. 9. IMPROVE PATIENT COMPLIANCE . 10. PRACTICE OF WRITING RATIONAL PRESCRIPTION. 11. STOPPING THE DRUG ABUSE. 12.QUALITY BLAME WOULD BE IN THE HANDS OF PHARMACIST. 13.RECORDS OF THE DRUG WOULD BE KEPT PROPE...

DRUG NAME  : ERYTHROMYCIN BACTERIAL RESISTANCE CLASS OF DRUG   :MACROLIDES. FOUNDED YEAR  : 1952 ISOLATED FROM:  STREPTOMYCES ERYTHREUS. MECHANISM OF ACTION :  BLOCKS 50S RIBOSOMES -INHIBITS THE PROTEIN SYNTHESIS  - BACTERICIDAL ACTIVITY. Macrolide antibiotics are bacteriostatic agents that inhibit protein synthesis by binding reversibly to the 50S ribosomal subunits of sensitive organisms. Erythromycin appears to inhibit the translocation step such that the nascent peptide chain temporarily residing at the A site fails to move to the P, or donor, site. Alternatively, macrolides may bind and cause a conformational change that terminates protein synthesis by indirectly interfering with transpeptidation and translocation   ANTIMICROBIAL SPECTRUM: streptococcus pyogenes streptococcus pneumoniae niseria gonorrhoeae clodtridia clostridium diphtheria clostridium listera campylobacter legionella branhamella catarrhalis gardnerella vaginallis mycoplasma Helico...